// App-Quantinova.ai

P2-11-06 : Assessment of ESR1 genomic aberrations and their role in endocrine therapy resistance in breast cancer

Researchers

Presenter

  • Carlos Martinez-Perez

Principal Investigators

  • Charlene Kay

  • James Meehan

  • Mark Gray

  • Rebecca Swan

  • Lorna Renshaw

  • Jane Keys

  • Andrew H Sims

  • Olga Oikonomidou

  • J Michael Dixon

  • Arran K Turnbull

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Estrogen Receptor 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved